Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
September 27, 2000

Carbamazepine Tablets Recalled

First public notice issued by FDA of 'completed recall'...

Carmel, IN (SafetyAlerts) - The Food and Drug Administration (FDA) has announced that Pharmaceutical Corporation of America is recalling its Carbamazepine Tablets, 200 mg, Rx because of a label mix-up - A portion of the lot was labeled as tetracycline 500 mg.

This is the first public notice of this Class II recall issued by FDA.

PRODUCT
Carbamazepine Tablets, 200 mg, Rx. NDC #51655-428-26.

Recall #D-470-0.

CODE
Lot #S302QJ EXP 10/31/01.

REPACKER
Pharmaceutical Corporation of America, Carmel, Indiana.

RECALLED BY
Repacker, by notifying the V.A. to return the goods on November 24, 1999. Firm-initiated recall **complete.

**Completed recall: While the FDA has completed processing of this particular recall, it does not mean this particular product has been fully accounted for.

DISTRIBUTION
Virginia.

QUANTITY
4,532 bottles were distributed; firm estimates none remains on the market.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.